191 related articles for article (PubMed ID: 2074280)
1. Evaluation of DNA ploidy in dysplastic and Spitz nevi by flow cytometry.
Winokur TS; Palazzo JP; Johnson WC; Duray PH
J Cutan Pathol; 1990 Dec; 17(6):342-7. PubMed ID: 2074280
[TBL] [Abstract][Full Text] [Related]
2. Comparison of image analysis with flow cytometry for DNA content analysis in pigmented lesions of the skin.
Sangueza OP; Hyder DM; White CR; Pallander J; Perkins M; Remple N; Bakke A
Anal Quant Cytol Histol; 1992 Feb; 14(1):55-9. PubMed ID: 1558616
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of DNA ploidy and degree of DNA abnormality in benign and malignant melanocytic lesions of the skin using video imaging.
Pilch H; Günzel S; Schäffer U; Tanner B; Heine M
Cancer; 2000 Mar; 88(6):1370-7. PubMed ID: 10717619
[TBL] [Abstract][Full Text] [Related]
4. A comparative study of proliferation indices and ploidy in dysplastic naevi and malignant melanomas using flow cytometry.
Slater SD; Cook MG; Fisher C; Wright NA; Foster CS
Histopathology; 1991 Oct; 19(4):337-44. PubMed ID: 1937413
[TBL] [Abstract][Full Text] [Related]
5. Multiparametric image cytometry of nevi and melanomas.
Fleming MG; Friedman RJ
Am J Dermatopathol; 1993 Apr; 15(2):106-13. PubMed ID: 8494109
[TBL] [Abstract][Full Text] [Related]
6. Significance of DNA ploidy measurements in Spitz nevi.
Skowronek J; Warchoł JB; Karaś Z; Krenz RM
Pol J Pathol; 2000; 51(1):45-50. PubMed ID: 10833903
[TBL] [Abstract][Full Text] [Related]
7. Detection of the BRAF V600E mutation in melanocytic lesions using the ligase detection reaction.
Turner DJ; Zirvi MA; Barany F; Elenitsas R; Seykora J
J Cutan Pathol; 2005 May; 32(5):334-9. PubMed ID: 15811117
[TBL] [Abstract][Full Text] [Related]
8. DNA ploidy and nuclear morphometry for the classification of dysplastic nevi.
Williams RA; Baak JP; Meijer GA; Charlton IG
Anal Quant Cytol Histol; 1999 Oct; 21(5):437-44. PubMed ID: 10560527
[TBL] [Abstract][Full Text] [Related]
9. Use of DAPI cytofluorometric analysis of cellular DNA content to differentiate Spitz nevus from malignant melanoma.
Chi HI; Ishibashi Y; Shima A; Mihara I; Otsuka F
J Invest Dermatol; 1990 Aug; 95(2):154-7. PubMed ID: 2380576
[TBL] [Abstract][Full Text] [Related]
10. Dysplastic nevus part II: Dysplastic nevi: Molecular/genetic profiles and management.
Spaccarelli N; Drozdowski R; Peters MS; Grant-Kels JM
J Am Acad Dermatol; 2023 Jan; 88(1):13-20. PubMed ID: 36252690
[TBL] [Abstract][Full Text] [Related]
11. DNA determination in dysplastic nevi. A comparative study between flow cytometry and image analysis.
Sangueza OP; Hyder DM; Bakke AC; White CR
Am J Dermatopathol; 1993 Apr; 15(2):99-105. PubMed ID: 8494124
[TBL] [Abstract][Full Text] [Related]
12. Number, size, and histopathology of nevi in Utah kindreds.
Meyer LJ; Goldgar DE; Cannon-Albright LA; Piepkorn MW; Zone JJ; Risman MB; Skolnick MH
Cytogenet Cell Genet; 1992; 59(2-3):167-9. PubMed ID: 1737489
[No Abstract] [Full Text] [Related]
13. Comprehensive analysis of 112 melanocytic skin lesions demonstrates microsatellite instability in melanomas and dysplastic nevi, but not in benign nevi.
Hussein MR; Sun M; Tuthill RJ; Roggero E; Monti JA; Sudilovsky EC; Wood GS; Sudilovsky O
J Cutan Pathol; 2001 Aug; 28(7):343-50. PubMed ID: 11437939
[TBL] [Abstract][Full Text] [Related]
14. Dysplastic nevi.
Farber MJ; Heilman ER; Friedman RJ
Dermatol Clin; 2012 Jul; 30(3):389-404. PubMed ID: 22800547
[TBL] [Abstract][Full Text] [Related]
15. Melanomas, dysplastic nevi and benign nevi: is dysplastic nevus a non-benign neoplasm?
Yus ES; Simon RS
J Cutan Pathol; 2002 Oct; 29(9):570; author reply 570-1. PubMed ID: 12358817
[No Abstract] [Full Text] [Related]
16. Genomic Characterization of Dysplastic Nevi Unveils Implications for Diagnosis of Melanoma.
Melamed RD; Aydin IT; Rajan GS; Phelps R; Silvers DN; Emmett KJ; Brunner G; Rabadan R; Celebi JT
J Invest Dermatol; 2017 Apr; 137(4):905-909. PubMed ID: 27890785
[TBL] [Abstract][Full Text] [Related]
17. Different patterns of expression of the erbB family of receptor tyrosine kinases in common nevi, dysplastic nevi, and primary malignant melanomas: an immunohistochemical study.
Feinmesser M; Veltman V; Morgenstern S; Tobar A; Gutman H; Kaganovsky E; Tzabari C; Sulkes J; Okon E
Am J Dermatopathol; 2010 Oct; 32(7):665-75. PubMed ID: 20559114
[TBL] [Abstract][Full Text] [Related]
18. Typical, dysplastic, congenital, and Spitz nevi: a comparative immunohistochemical study.
Palazzo J; Duray PH
Hum Pathol; 1989 Apr; 20(4):341-6. PubMed ID: 2703228
[TBL] [Abstract][Full Text] [Related]
19. Melanocytic nevi with features of Spitz nevi and Clark's/dysplastic nevi ("Spark's" nevi).
Ko CJ; McNiff JM; Glusac EJ
J Cutan Pathol; 2009 Oct; 36(10):1063-8. PubMed ID: 19187111
[TBL] [Abstract][Full Text] [Related]
20. Multivariate DNA cytometry discriminates between Spitz nevi and malignant melanomas because large polymorphic nuclei in Spitz nevi are not aneuploid.
Vogt T; Stolz W; Glässl A; Abmayr W; Hohenleutner U; Schmoeckel C; Schiffner R; Landthaler M
Am J Dermatopathol; 1996 Apr; 18(2):142-50. PubMed ID: 8739988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
